Evidence map›Paper›PMID 32453694›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2020

Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.

Wassim Kassouf, Armen Aprikian, Fred Saad, Neil Fleshner, Nimira Alimohamed, Rodney H Breau, Fadi Brimo, Joe Chin, Peter Chung, Tony Cornacchia and 27 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Establishing maximal wait times for urologic surgery in Canada in 2024.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  2. Article
  3. Article
  4. Real-life benchmarking bladder cancer care: A population-based study.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  5. Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  6. Building a Canadian Translational Bladder Cancer Research Network.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Wassim KassoufDepartments of Urology, McGill University Health Centre, Montreal, QC, Canada.
Armen AprikianDepartments of Urology, McGill University Health Centre, Montreal, QC, Canada.
Fred SaadDivision of Urology, Université de Montréal, Montreal, QC, Canada.
Neil FleshnerDepartments of Surgery (Urology) and Surgical Oncology, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada.
Nimira AlimohamedDivision of Medical Oncology, University of Calgary, Calgary, AB, Canada.
Rodney H BreauDivisions of Urology, University of Ottawa, Ottawa, ON, Canada.
Fadi BrimoDepartment of Pathology, McGill University Health Centre, Montreal, QC, Canada.
Joe ChinDivision of Urology, Western University, London, ON, Canada.
Peter ChungDepartment of Radiation Oncology, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada.
Tony CornacchiaPatient representative, Bladder Cancer Canada.
Ferg DevinsPatient representative, Bladder Cancer Canada.
Libni EapenDivision of Radiation Oncology, University of Ottawa, Ottawa, ON, Canada.
Bernie EiglBC Cancer Agency, Vancouver, BC, Canada.
Adrian FaireyDivision of Urology, University of Alberta, Edmonton, AB, Canada.
David GuttmanPatient representative, Bladder Cancer Canada.
Jason P IzardDepartments of Urology and Oncology, Queen's University, Kingston, ON, Canada.
Niels JacobsenDivision of Urology, University of Alberta, Edmonton, AB, Canada.
Claudio JeldresDivision of Urology, University of Sherbrooke, Sherbrooke, QC, Canada.
Girish KulkarniDepartment of Surgical Oncology, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada.
Aly-Khan LalaniDivision of Medical Oncology, McMaster University, Hamilton, ON, Canada.
Michele LoddeDepartment of Urology, Université Laval, Quebec City, QC, Canada.
Himu LukkaDivision of Medical Oncology, McMaster University, Hamilton, ON, Canada.
Ron MooreDivision of Urology, University of Alberta, Edmonton, AB, Canada.
Chris MorashDivisions of Urology, University of Ottawa, Ottawa, ON, Canada.
Scott NorthDivision of Medical Oncology, University of Alberta, Edmonton, AB, Canada.
Tammy NorthamPatient representative, Bladder Cancer Canada.
Michael OngDivision of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
Nick PowerDivision of Urology, Western University, London, ON, Canada.
Ricardo RendonDivision of Urology, Dalhousie University, Halifax, NS, Canada.
Robert PurvesPatient representative, Bladder Cancer Canada.
Bobby ShayeganDivision of Urology, McMaster University, Hamilton, ON, Canada.
Randy SmithPatient representative, Bladder Cancer Canada.
Alan SoDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Srikala S SridharDepartment of Medical Oncology, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada.
Alex ZlottaDepartments of Surgery (Urology) and Surgical Oncology, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, ON, Canada.
D Robert SiemensDepartments of Urology and Oncology, Queen's University, Kingston, ON, Canada.
Peter C BlackDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32453694
PMCPMC7053365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.